CD4+ T cells cooperate with macrophages for specific elimination of MHC class II-negative cancer cells.
Corthay
Alexandre
A
Institute of Immunology, University of Oslo and Rikshospitalet-Radiumhospitalet Medical Center, 0027 Oslo, Norway. Alexandre.Corthay@medisin.uio.no
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D045744:Cell Line, Tumor; D003094:Collagen; D016207:Cytokines / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000172:deficiency; D003713:Dendritic Cells / Q000276:immunology; D004338:Drug Combinations; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007157:Immunologic Surveillance; D016219:Immunotherapy, Adoptive; D007371:Interferon-gamma / Q000502:physiology; D007797:Laminin; D008198:Lymph Nodes / Q000276:immunology; D008213:Lymphocyte Activation; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D018345:Mice, Knockout; D016513:Mice, SCID; D008822:Mice, Transgenic; D009368:Neoplasm Transplantation / Q000379:methods; D009374:Neoplasms, Experimental / Q000276:immunology / Q000473:pathology / Q000628:therapy; D011509:Proteoglycans; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D037182:T-Cell Antigen Receptor Specificity; D016176:T-Lymphocyte Subsets / Q000276:immunology
D016207:Cytokines; D004268:DNA-Binding Proteins; D004338:Drug Combinations; D000949:Histocompatibility Antigens Class II; D007797:Laminin; D011509:Proteoglycans; C499308:Rag2 protein, mouse; D011948:Receptors, Antigen, T-Cell; C059485:matrigel; D007371:Interferon-gamma; D003094:Collagen